Author | Mohammad Qasim, MD


Biologic Therapy: Hematopoietic Growth Factors, Retinoids, and Monoclonal Antibodies

April 02, 2005

ByMohammad Qasim, MD|Paula Marlton, MBBS|Razelle Kurzrock, MD

Biologic therapies are an increasingly important part of cancer treatment. In this chapter, we review the current status of studies of colony-stimulating factors (CSFs), erythropoietin (Epogen, Procrit), thrombopoietin, the retinoids, and monoclonal antibodies (MoAbs). The interferons, interleukin-2 (IL-2, aldesleukin [Proleukin]), and adoptive cellular immunotherapy are discussed in a separate chapter.